Multiple pathological mechanisms are involved in the development of chemotherapy-
induced peripheral neurotoxicity (CIPN). Recent work has provided insights into the …

Early palliative care (EPC) significantly improves quality of life, symptoms, and satisfaction
with care for patients with advanced cancer. International organizations have recognized …

Chemotherapy-induced peripheral neurotoxicity (CIPN) is a major dose-limiting side effect of
many anti-cancer agents, including taxanes, platinums, vinca alkaloids, proteasome …

Simple Summary This article highlights the importance of monitoring peripheral neurotoxicity
in patients with Hodgkin lymphoma (HL) who receive brentuximab vedotin, with a particular …

Vincristine (VCR), an effective antitumor drug, has been utilized in several polytherapy
regimens for acute lymphoblastic leukemia, neuroblastoma and rhabdomyosarcoma …

Background: Survival in multiple myeloma (MM) has improved in the past years with the
introduction of immunomodulators and proteasome inhibitors. However …

Chemotherapy is one of the main treatments for hematologic malignancies. However,
chemotherapy‐induced peripheral neuropathy (CIPN) is one of the most common long‐term …

Background A combination of rituximab with cyclophosphamide, doxorubicin, vincristine,
and prednisone (R-CHOP) is the standard first-line therapy for diffuse large B cell lymphoma …

Chemo-and immune therapies administered to treat haematologic malignancies frequently
cause neurologic injury. The adverse events range from mild cognitive impairment and …

Autoimmunity in inborn errors of immunity (IEIs) has a multifactorial pathogenesis and
develops subsequent to a genetic predisposition in conjunction with gene regulation …